Aim: Infants with Hypoplastic Left Heart Syndrome(HLHS) may suffer inhibited growth. Some papershave shown it in congenital heart disease. Aim:to check if that is true in HLHS. We will also ...
FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease. NEW YORK, Dec. 04, 2024 (GLOB ...